Skip to main content

Advertisement

Log in

Safety and efficacy of tranexamic acid in children with cerebral palsy undergoing femoral varus derotational osteotomy: a double cohort study

  • Original Article
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

Aims

The safety and efficacy of tranexamic acid (TXA) in reducing blood loss after total joint arthroplasty and spinal fusion surgery has been well documented. However, little data exist regarding the effectiveness of intraoperative TXA in children with cerebral palsy (CP). The aim of this double cohort study is to investigate the safety and efficacy of intraoperative TXA in reducing blood loss and transfusion requirements for children with CP undergoing a proximal unilateral or bilateral femoral varus derotational osteotomy (VDRO).

Patients and methods

A retrospective review was performed of all paediatric theatre lists between May 2012 and January 2019 for all paediatric (< 16 years old) CP patients who underwent unilateral or bilateral VDRO combined with soft tissue release at our institution. Fifty-one patients were included in our study further subdivided into two individual groups, unilateral and bilateral VDRO.

Results

No statistically significant differences were found in demographics such as age, weight, ASA, GMFCS and antiepileptic medication between the groups. However, there were significant statistically differences in TBL and transfusion rates between the groups that received TXA and those that did not, both in unilateral [241 ml (TXA) vs. 369 ml (non-TXA)] and bilateral [287 ml (TXA) vs. 467 ml (non-TXA)] operations.

Conclusion

TXA successfully reduced TBL (in both TXA subgroups) and the transfusion rates without associated complications. TXA’s safety and efficacy should be explored further in adequately powered randomized controlled trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim T (2013) An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol 55(6):509–519

    Article  Google Scholar 

  2. Alassaf N, Saran N, Benaroch T, Hamdy RC (2018) Combined pelvic and femoral reconstruction in children with cerebral palsy. J Int Med Res 46(1):475–484

    Article  Google Scholar 

  3. Schwartz MH, Rozumalski A, Novacheck TF (2014) Femoral derotational osteotomy: surgical indications and outcomes in children with cerebral palsy. Gait Posture 39(2):778–783

    Article  Google Scholar 

  4. Chambers HG, Weinstein CH, Mubarak SJ, Wenger DR, Silva PD (1999) The effect of valproic acid on blood loss in patients with cerebral palsy. J Pediatr Orthop 19(6):792–795

    CAS  PubMed  Google Scholar 

  5. Majid I, Alshryda S, Somanchi B, Morakis E, Foster A (2015) The value of tranexamic acid in reducing blood loss following hip reconstruction in children with cerebral palsy. J Blood Transfus 2015:827027

    Article  CAS  Google Scholar 

  6. Tzatzairis TK, Drosos GI, Kotsios SE, Ververidis AN, Vogiatzaki TD, Kazakos KI (2016) Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study. J Arthroplas 31(11):2465–2470

    Article  Google Scholar 

  7. Sui WY, Ye F, Yang JL (2016) Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery. BMC Musculoskelet Disord 17:187

    Article  Google Scholar 

  8. Zhang Y, Zhang X, Wang Y, Shi J, Yuan S, Duan F et al (2019) Efficacy and safety of tranexamic acid in pediatric patients undergoing cardiac surgery: a single-center experience. Front Pediatr 7:181

    Article  Google Scholar 

  9. Urban D, Dehaeck R, Lorenzetti D, Guilfoyle J, Poon MC, Steele M et al (2016) Safety and efficacy of tranexamic acid in bleeding paediatric trauma patients: a systematic review protocol. BMJ Open 6(9):e012947

    Article  Google Scholar 

  10. Themistoklis T, Theodosia V, Konstantinos K, Georgios DI (2017) Perioperative blood management strategies for patients undergoing total knee replacement: where do we stand now? World J Orthop 8(6):441–454

    Article  Google Scholar 

  11. Nazareth A, Shymon SJ, Andras L, Goldstein RY, Kay RM (2019) Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy. J Child Orthop 13(2):190–195

    Article  CAS  Google Scholar 

  12. Dhawale AA, Shah SA, Sponseller PD, Bastrom T, Neiss G, Yorgova P et al (2012) Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis? Spine (Phila Pa 1976) 37(9):E549–E555

    Article  Google Scholar 

  13. Davies P, Robertson S, Hegde S, Greenwood R, Massey E, Davis P (2007) Calculating the required transfusion volume in children. Transfusion 47(2):212–216

    Article  Google Scholar 

  14. Batıbay S (2018) Is tranexamic acid safe and reliable after tibia intramedullary nailing? Turk J Trauma Emerg Surg 24:575

    Google Scholar 

  15. Iseki T, Tsukada S, Wakui M, Yoshiya S (2018) Intravenous tranexamic acid only versus combined intravenous and intra-articular tranexamic acid for perioperative blood loss in patients undergoing total knee arthroplasty. Eur J Orthop Surg Traumatol 28(7):1397–1402

    Article  Google Scholar 

  16. Tzatzairis T, Drosos GI, Vogiatzaki T, Tilkeridis K, Ververidis A, Kazakos K (2019) Multiple intravenous tranexamic acid doses in total knee arthroplasty without tourniquet: a randomized controlled study. Arch Orthop Trauma Surg 139(6):859–868

    Article  Google Scholar 

  17. Halanski MA, Cassidy JA, Hetzel S, Reischmann D, Hassan N (2014) The efficacy of amicar versus tranexamic acid in pediatric spinal deformity surgery: a prospective, randomized, double-blinded pilot study. Spine Deform 2(3):191–197

    Article  Google Scholar 

  18. McNicol ED, Tzortzopoulou A, Schumann R, Carr DB, Kalra A (2016) Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 9:CD006883

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Tzatzairis.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tzatzairis, T., McMahon, S., Shilpa, J. et al. Safety and efficacy of tranexamic acid in children with cerebral palsy undergoing femoral varus derotational osteotomy: a double cohort study. Eur J Orthop Surg Traumatol 30, 1039–1044 (2020). https://doi.org/10.1007/s00590-020-02663-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-020-02663-w

Keywords

Navigation